News Image

Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts

Provided By PR Newswire

Last update: Nov 25, 2024

ITASCA, Ill., Nov. 25, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), announces that Hupan Pharmaceutical (Hubei) Co., Ltd. ("Hupan Pharmaceutical"), a company recently acquired by Lakeside, has established partnership with Sinopharm Group Hubei Co., Ltd. ("Sinopharm Hubei"). Sinopharm Hubei is a subsidiary of Sinopharm Group Co., Ltd., a leader in China's pharmaceutical industry. This partnership for essential medicine storage, transportation, and logistics services positions Lakeside for accelerated growth and solidifies its foothold in China's medical logistics sector.

Read more at prnewswire.com

LAKESIDE HOLDING LTD

NASDAQ:LSH (12/8/2025, 8:23:07 PM)

0.781

-0.02 (-2.48%)



Find more stocks in the Stock Screener

Follow ChartMill for more